Effects of dorzolamide on choroidal blood flow, ciliary blood flow, and aqueous production in rabbits

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 5, 2009, Pages 2301-2307

  Reitsamer, Herbert A ^a,b   Bogner, Barbara ^a   Tockner, Birgit ^a   Kiel, Jeffrey W ^b  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE INHIBITOR; DORZOLAMIDE; SULFONAMIDE; THIOPHENE DERIVATIVE;

ANIMAL EXPERIMENT; AORTA OCCLUSION; AQUEOUS HUMOR FLOW; AQUEOUS HUMOR FORMATION; ARTICLE; BLOOD FLOW; CAVA VEIN OBSTRUCTION; CHOROID; CHOROIDAL BLOOD FLOW; CILIARY BLOOD FLOW; CILIARY BODY; CONTROLLED STUDY; FEMALE; FLUOROPHOTOMETRY; HEMODYNAMICS; INTRAOCULAR PRESSURE; LASER DOPPLER FLOWMETRY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SCLERA; VASCULAR RESISTANCE; VITREOUS BODY; ANIMAL; AQUEOUS HUMOR; BLOOD FLOW VELOCITY; BLOOD PRESSURE; DRUG EFFECT; PHYSIOLOGY; SECRETION; TOPICAL DRUG ADMINISTRATION; VASCULARIZATION; VASODILATATION;

ADMINISTRATION, TOPICAL; ANIMALS; AQUEOUS HUMOR; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CARBONIC ANHYDRASE INHIBITORS; CHOROID; CILIARY BODY; FEMALE; FLUOROPHOTOMETRY; INTRAOCULAR PRESSURE; LASER-DOPPLER FLOWMETRY; MALE; RABBITS; REGIONAL BLOOD FLOW; SULFONAMIDES; THIOPHENES; VASODILATION;

EID: 65549104355     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2468     Document Type: Article

References (47)

1. McKinnon SJ, Goldberg LD, Peeples P, Walt JG, Bramley TJ. Current management of glaucoma and the need for complete therapy. Am J Manag Care. 2008; 14:S20-S27.
2. Becker B. Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, diamox; a preliminary report. Am J Ophthalmol. 1954; 37:13-15.
3. Bill A. Effects of acetazolamide and carotid occlusion on the ocular blood flow in unanesthetized rabbits. Invest Ophthalmol. 1974; 13:954-958.
4. Herkel U, Pfeiffer N. Update on topical carbonic anhydrase inhibitors. Curr Opin Ophthalmol. 2001; 12:88-93.
5. Sugrue MF. Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors. Prog Retin Eye Res. 2000; 19:87-112.
6. Lippa EA, Schuman JS, Higginbotham EJ, et al. MK-507 versus sezolamide: comparative efficacy of two topically active carbonic anhydrase inhibitors. Ophthalmology. 1991; 98:308-312; discussion 312-313.
7. Sugrue MF, Mallorga P, Schwam H, Baldwin JJ, Ponticello GS. A comparison of L-671152 and MK-927, two topically effective ocu-lar hypotensive carbonic anhydrase inhibitors, in experimental animals. Curr Eye Res. 1990; 9:607-615.
8. Wang RF, Serle JB, Podos SM, Sugrue MF. The ocular hypotensive effect of the topical carbonic anhydrase inhibitor L-671152 in glaucomatous monkeys. Arch Ophthalmol. 1990; 108:511-513.
9. Grunwald JE, Mathur S, DuPont J. Effects of dorzolamide hydrochloride 2% on the retinal circulation. Acta Ophthalmol Scand. 1997; 75(3):236-238.
10. Tamaki Y, Araie M, Muta K. Effect of topical dorzolamide on tissue circulation in the rabbit optic nerve head. Jpn J Ophthalmol. 1999; 43:386-391.
11. Bergstrand IC, Heijl A, Harris A. Dorzolamide and ocular blood flow in previously untreated glaucoma patients: a controlled double-masked study. Acta Ophthalmol Scand. 2002; 80:176-182.
12. Simsek T, Yanik B, Conkbayir I, Zilelioglu O. Comparative analysis of the effects of brimonidine and dorzolamide on ocular blood flow velocity in patients with newly diagnosed primary open-angle glaucoma. J Ocul Pharmacol Ther. 2006; 22:79-85.
13. Okada Y, Ichikawa M, Ishii K, Hara H. Effects of topically instilled bunazosin hydrochloride and other ocular hypotensive drugs on endothelin-1-induced constriction in rabbit retinal arteries. Jpn J Ophthalmol. 2004; 48:465-469.
14. Zeitz O, Matthiessen ET, Reuss J, et al. Effects of glaucoma drugs on ocular hemodynamics in normal tension glaucoma: a randomized trial comparing bimatoprost and latanoprost with dorzol-amide [ISRCTN18873428]. BMC Ophthalmol. 2005; 5:6.
15. Barnes GE, Li B, Dean T, Chandler ML. Increased optic nerve head blood flow after 1 week of twice daily topical brinzolamide treat-ment in Dutch-belted rabbits. Surv Ophthalmol. 2000; 44(Suppl 2):S131-S40.
16. Harris A, Arend O, Arend S, Martin B. Effects of topical dorzolamide on retinal and retrobulbar hemodynamics. Acta Ophthal-mol Scand. 1996; 74:569-572.
17. Schmidt KG, von Ruckmann A, Pillunat LE. Topical carbonic anhydrase inhibition increases ocular pulse amplitude in high tension primary open angle glaucoma. Br J Ophthalmol. 1998; 82:758-762.
18. Schmidt KG, Dick B. von Ruckmann A, Pillunat LE. Ocular pulse amplitude and local carbonic anhydrase inhibition (in German). Ophthalmologe. 1997; 94:659-664.
19. Pedersen DB, Koch Jensen P, la Cour M., et al. Carbonic anhydrase inhibition increases retinal oxygen tension and dilates retinal ves-sels. Graefes Arch Clin Exp Ophthalmol. 2005; 243:163-168.
20. Stefansson E, Jensen PK, Eysteinsson T, et al. Optic nerve oxygen tension in pigs and the effect of carbonic anhydrase inhibitors. Invest Ophthalmol Vis Sci. 1999; 40:2756-2761.
21. Josefsson A, Sigurdsson SB, Bang K, Eysteinsson T. Dorzolamide induces vasodilatation in isolated pre-contracted bovine retinal arteries. Exp Eye Res. 2004; 78:215-221.
22. Kehler AK, Holmgaard K, Hessellund A, Aalkjaer C, Bek T. Variable involvement of the perivascular retinal tissue in carbonic anhydrase inhibitor induced relaxation of porcine retinal arterioles in vitro. Invest Ophthalmol Vis Sci. 2007; 48:4688-4693.
23. Kiel JW, van Heuven WAJ. Ocular perfusion pressure and choroidal blood flow in the rabbit. Invest Ophthalmol Vis Sci. 1995; 36: 579-585.
24. Reitsamer HA, Kiel JW. A rabbit model to study orbital venous pressure, intraocular pressure, and ocular hemodynamics simultaneously. Invest Ophthalmol Vis Sci. 2002; 43:3728-3734.
25. Reitsamer HA, Kiel JW. Relationship between ciliary blood flow and aqueous production in rabbits. Invest Ophthalmol Vis Sci. 2003; 44:3967-3971.
26. Kiel JW, Reitsamer HA. Relationship between ciliary blood flow and aqueous production: does it play a role in glaucoma therapy? J Glaucoma. 2006; 15:172-181.
27. Gabelt BT, Kiland JA, Tian B, Kaufman PL. Aqueous humor: secretion and dynamics. In: Tasman W, Jaeger EA, eds. Duane's Clinical Ophthalmology. Vol. 2. Philadelphia: Lippincott Williams & Wilkins; 2006:chap 6.
28. Matsui H, Murakami M, Wynns GC, et al. Membrane carbonic anhydrase (IV) and ciliary epithelium: carbonic anhydrase activity is present in the basolateral membranes of the non-pigmented ciliary epithelium of rabbit eyes. Exp Eye Res. 1996; 62:409-417.
29. Wang RF, Serle JB, Podos SM, Sugrue MF. MK-507 (L-671152), a topically active carbonic anhydrase inhibitor, reduces aqueous humor production in monkeys. Arch Ophthalmol. 1991; 109: 1297-1299.
30. Camras CB, Bito LZ. The pathophysiological effects of nitrogen mustard on the rabbit eye. II. The inhibition of the initial hypertensive phase by capsaicin and the apparent role of substance P. Invest Ophthalmol Vis Sci. 1980; 19:423-428.
31. Neufeld AH, Jampol LM, Sears ML. Aspirin prevents the disruption of the blood-aqueous barrier in the rabbit eye. Nature. 1972; 238: 158-159.
32. Sears ML. Miosis and intraocular pressure changes during manometry. Arch Ophthalmol. 1960; 63:159-166.
33. Brubaker RF. Flow of aqueous humor in humans. Invest Ophthalmol Vis Sci. 1991; 32:3145-3166.
34. Topper JE, McLaren J, Brubaker RF. Measurement of aqueous humor flow with scanning ocular fluorophotometers. Cur Eye Res. 1984; 3:1391-1395.
35. Shepherd AP, Oberg PA. Laser-Doppler Blood Flowmetry. Norwell, MA: Kluwer Academic Publishers; 1990.
36. Kiel JW, Reitsamer HA, Walker JS, Kiel FW. Effects of nitric oxide synthase inhibition on ciliary blood flow, aqueous production and intraocular pressure. Exp Eye Res. 2001; 73:355-364.
37. Reitsamer HA, Posey M, Kiel JW. Effects of a topical alpha2 adrenergic agonist on ciliary blood flow and aqueous production in rabbits. Exp Eye Res. 2006; 82:405-415.
38. Reitsamer HA, Kiel JW. Effects of dopamine on ciliary blood flow, aqueous production, and intraocular pressure in rabbits. Invest Ophthalmol Vis Sci. 2002; 43:2697-2703.
39. Kiel JW. Modulation of choroidal autoregulation in the rabbit. Exp Eye Res. 1999; 69:413-429.
40. Pillunat LE, Bohm AG, Koller AU, et al. Effect of topical dorzolamide on optic nerve head blood flow. Graefe's Arch Clin Exp Ophthalmol. 1999; 237:495-500.
41. Inoue J, Oka M, Aoyama Y, et al. Effects of dorzolamide hydrochloride on ocular tissues. J Ocul Pharmacol Ther. 2004; 20:1-13.
42. Martinez A, Gonzalez F, Capeans C, Perez R, Sanchez-Salorio M. Dorzolamide effect on ocular blood flow Invest Ophthalmol Vis Sci. 1999; 40:1270-1275.
43. Arend O, Harris A, Wolter P, Remky A. Evaluation of retinal haemodynamics and retinal function after application of dorzolamide, timolol and latanoprost in newly diagnosed open-angle glaucoma patients. Acta Ophthalmol Scand. 2003; 81:474-479.
44. Fuchsjager-Mayrl G, Wally B, Rainer G, et al. Effect of dorzolamide and timolol on ocular blood flow in patients with primary open angle glaucoma and ocular hypertension. Br J Ophthalmol. 2005; 89:1293-1297.
45. Costagliola C, Campa C, Parmeggiani F, et al. Effect of 2% dorzolamide on retinal blood flow: a study on juvenile primary open-angle glaucoma patients already receiving 0.5% timolol. Br J Clin Pharmacol. 2007; 63:376-379.
46. Noergaard MH, Bach-Holm D, Scherfig E, et al. Dorzolamide increases retinal oxygen tension after branch retinal vein occlusion. Invest Ophthalmol Vis Sci. 2008; 49:1136-1141.
47. Holm L, Perry MA. Role of blood flow in gastric acid secretion. Am J Physiol. 1988; 254:G281-G293.